- [Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
[Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
Deutsche medizinische Wochenschrift (1946) (2014-05-08)
G J Molderings, J Homann, S Brettner, M Raithel, T Frieling
PMID24801454
ABSTRACT
In the present paper clinical phenotypes, pathogenetic relationships, and diagnostic algorithms as well as therapeutic concepts of/for systemic mast cell activation disease are reviewed. The reader should be able to recognize and diagnose a systemic mast cell activation disease, as well as to counsel a personalized drug therapy. In the case of chronic multisystem polymorbidity systemic mast cell activation disease should be considered as a differential diagnosis at an early stage. In most cases, specific, little invasive investigations allow diagnosing the disease and, hence, an appropriate therapy can be initiated.
MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto
Sigma-Aldrich
Acido L-ascorbico, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Acido L-ascorbico, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Supelco
(+)- L-ascorbato di sodio, Pharmaceutical Secondary Standard; Certified Reference Material
Acido L-ascorbico, European Pharmacopoeia (EP) Reference Standard
(+)- L-ascorbato di sodio, European Pharmacopoeia (EP) Reference Standard
Supelco
Acido L-ascorbico, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Ranitidine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Ketotifen hydrogen fumarate, European Pharmacopoeia (EP) Reference Standard
Ranitidine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ketotifen for peak identification, European Pharmacopoeia (EP) Reference Standard